Fresh off a record year for profit and revenue, JPMorgan is facing questions over what CFO Jeremy Barnum admitted was excess ...
JPMorgan Chase & Co.'s Chief Executive Jamie Dimon told analysts on Wednesday he plans to stay in the job "for a few more ...
Big bank profits surged in the fourth quarter and Wall Street roared back to life, with net income rising 50% at JPMorgan ...
The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...
JPMorgan Chase & Co.'s Chief Executive Jamie Dimon said the U.S. economy remains "resilient" but he remains wary of inflation ...
JPMorgan Chase said Tuesday that Chief Operating Officer and President Daniel Pinto will step down from those roles in the ...
JPMorgan Chase management disabled comments on an internal webpage where the policy was announced, according to the Wall ...
JPMorgan Chase reported fourth-quarter results Wednesday that came in above analysts' expectations as investment banking fees ...
JPMorgan Chase significantly exceeded fourth-quarter expectations with strong earnings, despite challenges like credit costs ...
GlobalData on MSN18h
JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized holeAbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...
Betsy Graseck, an analyst from Morgan Stanley, maintained the Hold rating on JPMorgan Chase & Co. (JPM – Research Report). The associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback